Cancer
Cancer
Defining Value in Cancer Care
For over a decade, Schaeffer Scholars have been defining value in cancer care by determining what is truly important to patients and developing innovative payment models addressing value, price and access.
Related Topics
Top Stories View All
Journal Article
Cancer Treatment Before and After Physician-Pharmacy Integration
Featured Experts: Genevieve P. Kanter
In The News View All
No news items.
Featured white paper
Cancer-Related Technologies Have Changed a Lot. So Should Cancer Screening.
Current cancer-screening and reimbursement paradigms should be revised to recognize the value of new technologies available.
Experts: Dana Goldman, Darius Lakdawalla, Karen Van Nuys
Op-eds and perspectives View All
Perspective
We Can Find Cancers with a Simple Blood Test
Featured Experts: Dana Goldman
In The News View All
No news items.
Featured Research
Newly Approved Cancer Drugs Are Pricey, But Also Show Improved Longer-Term Survival Gains
Do the clinical gains offered by these drugs in treating specific cancer indications justify the price increases? Schaeffer Center researchers Alice Chen and Dana Goldman explore how we might measure the value of these drugs.
Experts: Alice Chen, Dana Goldman
